- Raised $77k grant, Nov 2019
- Raised Undisclosed Round led by Smart Funding, Nov 2020
About
Ela Pharma is a biotechnology company developing innovative drugs designed to address clinical conditions caused by necrosis. The company's drug development process is based on a new platform for anti-necrosis technology, which directly inhibits an intracellular proteolytic enzyme that plays a critical role in the regulation of the necrosis pathway. Necrosis is a major mode of cell death associated with various diseases that currently lack drug-based cures, including myocardial infarction, ischemic diseases, brain stroke, traumatic brain injury, neurodegenerative diseases, liver failure, chronic hepatitis, pancreatitis, and acute macular degeneration. Ela Pharma's technology also has potential applications in organ preservation, aiming to extend the viability of organs for transplantation.
Funding history · 2 rounds · $77K total
Q&A
- What is Ela Pharma's primary focus?
- Ela Pharma is a biotechnology company developing innovative drugs designed to address clinical conditions caused by necrosis, utilizing a new platform for anti-necrosis technology.
- Where is Ela Pharma headquartered?
- Ela Pharma is headquartered in Tel Aviv-Yafo, Israel.
- When was Ela Pharma founded?
- Ela Pharma was founded in June 2015.
- How many employees does Ela Pharma have?
- Ela Pharma has 1-10 employees.
- Who are the co-founders of Ela Pharma?
- The co-founders of Ela Pharma are Roi Paul Nathan, who also serves as CEO, and Ilana Nathan.
- What is Ela Pharma's current funding stage?
- Ela Pharma is currently in the Seed funding stage.
- Has Ela Pharma received any grant funding?
- Yes, Ela Pharma received a Grant round in December 2019 from EU Horizon 2020, totaling $77,000.
- What is Ela Pharma's technology based on?
- Ela Pharma's technology is based on a novel approach that directly inhibits an intracellular proteolytic enzyme critical in regulating necrosis pathways, using small molecules as anti-necrosis agents.
- Does Ela Pharma hold any patents?
- Yes, Ela Pharma holds 1 patent.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | elapharma.com/ |
|---|---|
| linkedin.com/company/18221536 |
Identifiers & details
| Founded | 2015-6 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | elapharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515279156 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-06-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | דורי 4 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |